Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study

OBJECTIVES: We explored efficacy and safety of IVIg as first-line treatment in patients with an idiopathic inflammatory myopathy. METHODS: In this investigator-initiated phase 2 open-label study, we included 20 adults with a newly diagnosed, biopsy-proven idiopathic inflammatory myopathy, and a dise...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Rheumatology (Oxford)
Auteurs principaux: Lim, Johan, Eftimov, Filip, Verhamme, Camiel, Brusse, Esther, Hoogendijk, Jessica E, Saris, Christiaan G J, Raaphorst, Joost, De Haan, Rob J, van Schaik, Ivo N, Aronica, Eleonora, de Visser, Marianne, van der Kooi, Anneke J
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Clinical Science
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8023983/
https://ncbi.nlm.nih.gov/pubmed/33099648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa459
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires